Table 2

Segmented regression of time-series results expressed in defined daily doses—prescription of antidepressants

Immediate impactChange in trendAbsolute change in outcome a month after COVID-19Relative change in outcome a month after COVID-19 (%)
B95% CIB95% CI
Male
 Children (≥7 yo)−131.65−439.62 to 176.32−12.17−47.23 to 22.90−143.82−23.23
 Adolescents (8–17 yo)−9808.52*−180 70.96 to −1546.07−2313.24*−3982.57 to −643.90−12 121.75−8.47
 Adults (18–64 yo)−99 413.19−325 900.12 to 127 073.73−37 988.11*−73 488.17 to −2488.06−137 401.30−3.37
 Older adults (65–74 yo)−21 996.52−112 863.08 to 68 870.04−18 402.10*−33 121.97 to −3682.23−40 398.63−1.92
 Elderly (≥75 yo)−17 503.89−122 518.89 to 87 511.12−17 232.59*−31 880.87 to −2584.30−34 736.47−1.57
Female
 Children (≥7 yo)−0.14−0.48 to 0.200.01−0.03 to 0.05−0.13−8.72
 Adolescents (8–17 yo)−20817.58*−33 061.47 to −8573.69−404.13−1967.06 to 1158.79−21 221.71−16.94
 Adults (18–64 yo)−383 600.69−1 156 313.53 to 389 112.14−91 526.60−201 911.88 to 18 858.67−475 127.30−3.25
 Older adults (65–74 yo)−218 185.26−460 427.56 to 24 057.05−24 970.70−61 175.54 to 11 234.14−243 155.96−3.99
 Elderly (≥75 yo)−293 440.34*−546 313.17 to −40 567.51−22 566.81−59 314.21 to 14 180.60−316 007.15−5.34
 Total−982 713.66−2 593 215.55 to 627 788.23−200 913.88−441 477.53 to 39 649.77)−1 183 627.54−3.55

  • *p<0.05